Submitted by Anonymous (not verified) on 27 May 2026 - 13:32
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 12, Status: Authorised